400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / ALK / ALK-IN-1
CAS No.: 1197958-12-5
Synonyms: Brigatinib analog;AP26113 analog
AP26113 is an analog of AP26113 which is a potent and selective ALK inhibitor. It is also an inhibitor of EGFR.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03087448 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | March 2021 | United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Collapse << |
NCT03546894 | - | - | Recruiting | June 14, 2021 | United States, Massachusetts ... more >> EmpiraMed, Inc. Recruiting Maynard, Massachusetts, United States, 01754 Collapse << |
NCT03737994 | ALK Gene Rearrangement ... more >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Collapse << | Phase 2 | Not yet recruiting | December 13, 2025 | - |
实验方案
技术信息
CAS号 | 1197958-12-5 | 储存条件 |
|
|||||||
分子式 | C26H34ClN6O2P | 运输 | 蓝冰 | |||||||
分子量 | 529.01 | 别名 | Brigatinib analog;AP26113 analog | |||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03087448 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | March 2021 | United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Collapse << |
NCT03546894 | - | - | Recruiting | June 14, 2021 | United States, Massachusetts ... more >> EmpiraMed, Inc. Recruiting Maynard, Massachusetts, United States, 01754 Collapse << |
NCT03737994 | ALK Gene Rearrangement ... more >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Collapse << | Phase 2 | Not yet recruiting | December 13, 2025 | - |
NCT03389399 | - | - | Recruiting | August 30, 2019 | United States, Colorado ... more >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Paula Fisk Principal Investigator: Camidge Ross, MD Principal Investigator: Terry Ng Collapse << |
NCT03410108 | ALK-positive Advanced NSCLC | Phase 2 | Recruiting | April 30, 2020 | Japan ... more >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan Nagoya University Hospital Recruiting Nagoya, Aichi, Japan Fujita Health University Hospital Recruiting Toyoake, Aichi, Japan National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan National Hospital Organization Shikoku Cancer Center Not yet recruiting Matsuyama, Ehime, Japan Kurume University Hospital Recruiting Kurume, Fukuoka, Japan Hokkaido Cancer Center Not yet recruiting Sapporo, Hokkaido, Japan Hyogo Cancer Center Recruiting Akashi, Hyogo, Japan Kobe City Medical Center General Hospital Recruiting Kobe, Hyogo, Japan Kanazawa University Hospital Not yet recruiting Kanazawa, Ishikawa, Japan Iwate Medical University Hospital Not yet recruiting Morioka, Iwate, Japan Kanagawa Cancer Center Recruiting Yokohama, Kanagawa, Japan Matsuzaka Citizen's Hospital Recruiting Matsuzaka, Mie, Japan Sendai Kousei Hospital Active, not recruiting Sendai, Miyagi, Japan Kurashiki Central Hospital Not yet recruiting Kurashiki, Okayama, Japan Kansai Medical University Hospital Recruiting Hirakata, Osaka, Japan Kindai University Hospital Recruiting Osakasayama, Osaka, Japan Saitama Cancer Center Not yet recruiting Ina, Saitama, Japan Shizuoka Cancer Center Recruiting Nagaizumi-cho, Shizuoka, Japan Jichi Medical University Hospital Recruiting Shimotsuke, Tochigi, Japan Juntendo University Hospital Recruiting Bunkyo-ku, Tokyo, Japan Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Recruiting Bunkyo-ku, Tokyo, Japan National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan Cancer Institute Hospital Active, not recruiting Koto-ku, Tokyo, Japan Chiba University Hospital Not yet recruiting Chiba, Japan Kyushu University Hospital Recruiting Fukuoka, Japan National Hospital Organization Kyushu Cancer Center Recruiting Fukuoka, Japan Kyoto University Hospital Recruiting Kyoto, Japan Niigata Cancer Center Hospital Recruiting Niigata, Japan Okayama University Hospital Recruiting Okayama, Japan Osaka City General Hospital Recruiting Osaka, Japan Osaka International Cancer Institute Recruiting Osaka, Japan Wakayama Medical University Hospital Not yet recruiting Wakayama, Japan Collapse << |
NCT03707938 | Advanced Lung Carcinoma ... more >> ALK Gene Rearrangement Non-Small Cell Lung Carcinoma Recurrent Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Collapse << | Early Phase 1 | Not yet recruiting | January 28, 2023 | United States, Texas ... more >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Vincent K. Lam 713-792-6363 Principal Investigator: Vincent K. Lam Collapse << |
NCT03535740 | ALK-positive Advanced NSCLC | Phase 2 | Not yet recruiting | April 22, 2022 | - |
NCT03596866 | ALK-positive Advanced NSCLC | Phase 3 | Not yet recruiting | September 4, 2023 | - |
NCT03719898 | Anaplastic Large Cell Lymphoma... more >>, ALK-Positive Collapse << | Phase 2 | Recruiting | December 2021 | United States, Pennsylvania ... more >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19011 Contact: Carlyn Tan, MD 215-728-4300 carlynrose.tan@tuhs.temple.edu Contact: Christiana Carns 215-214-6922 Christiana.Carns@tuhs.temple.edu Collapse << |
NCT02784158 | - | - | - | - | United States, California ... more >> UC San Diego Moores Cancer Center (Site 099) La Jolla, California, United States, 92093-0698 UCI Medical Center-Chao Family Comprehensive (Site 210) Orange, California, United States, 92868-3201 United States, Michigan Karmanos Cancer Institute (Site 070) Detroit, Michigan, United States, 48201 Collapse << |
NCT03420742 | Carcinoma, Advanced ALK+ or RO... more >>S1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors Collapse << | Phase 1 | Not yet recruiting | August 18, 2020 | France ... more >> Groupe Hospitalier Bichat-Claude Bernard - Hopital Bichat Not yet recruiting Paris, Ile-de-france, France, 75018 Hopital de la Timone Not yet recruiting Marseille Cedex 5, Provence Alpes COTE D'azur, France, 13385 Hopital de la Timone Not yet recruiting Marseille, Provence Alpes COTE D'azur, France, 13005 Italy Centro di Riferimento Oncologico di Aviano Not yet recruiting Aviano, Pordenone, Italy, 33081 Policlinico Sant'Orsola Malpighi Not yet recruiting Bologna, Italy, 40138 Ospedale San Raffaele Not yet recruiting Milano, Italy, 20132 Istituto Europeo di Oncologia Not yet recruiting Milano, Italy, 20141 Azienda Ospedaliero Universitaria di Parma Not yet recruiting Parma, Italy, 43126 Ospedale "degli Infermi" di Faenza Not yet recruiting Ravenna, Italy, 48121 Netherlands Netherlands Cancer Institute Not yet recruiting Amsterdam, Noord-holland, Netherlands, 1006 CX Spain Hospital Universitario Dexeus, Not yet recruiting Barakaldo, Vizcaya, Spain, 48903 Hospital Universitario Dexeus Not yet recruiting Barcelona, Spain, 08028 Hospital Universitari Vall d'Hebron Not yet recruiting Barcelona, Spain, 08035 Hospital Universitario Ramon Y Cajal Not yet recruiting Madrid, Spain, 28034 Hospital Universitario Fundacion Jimenez Diaz Not yet recruiting Madrid, Spain, 28040 HM Centro Integral Oncologico Clara Campal Not yet recruiting Madrid, Spain, 28050 Collapse << |
NCT02706626 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | January 2020 | United States, Colorado ... more >> University Of Colorado Recruiting Denver, Colorado, United States, 80045 Contact: Anna Wynfield 720-848-5278 anna.wynfield@ucdenver.edu Contact: Paula Fisk 720-848-0676 Paula.Fisk@ucdenver.edu Principal Investigator: David R Camidge, MD United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Debra Shoemaker, RN 919-681-4768 Debra.shoemaker@duke.edu Principal Investigator: Thomas E Stinchcombe, MD United States, Tennessee Vanderbilt Unversity Medical Center Recruiting Nashville, Tennessee, United States, 37203 Contact: Kathy Taylor 615-875-0060 kathy.l.taylor@vanderbilt.edu Principal Investigator: Leora Horn, MD United States, Texas University of Texas, Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Jessica Saltarski 214-648-1688 Jessica.Saltarski@UTSouthwestern.edu Principal Investigator: David Gerber, MD Collapse << |
NCT01449461 | Lymphoma, Large-Cell, Anaplast... more >>ic Carcinoma, Non-Small-Cell Lung Collapse << | Phase 1 Phase 2 | Active, not recruiting | July 8, 2019 | - |
NCT01449461 | - | - | Active, not recruiting | - | - |
NCT02094573 | - | - | Active, not recruiting | - | - |
NCT02737501 | Non-small Cell Lung Cancer ... more >> Lung Cancer Advanced Malignancies Carcinoma Collapse << | Phase 3 | Active, not recruiting | July 31, 2020 | - |
NCT02094573 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Active, not recruiting | September 21, 2020 | - |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网